Chr. Hansen Holding

432,4 DKK +1,22 %

Ole ensimmäinen seuraaja

Christian Hansen Holding is a global food group. Today, the business focus is on the development of enzymes and natural dyes that are used as additives in the food industry. A large part of the business includes research and development of good bacteria that are added to various probiotic products. The company was founded in 1874 and is headquartered in Hørsholm, Denmark.

Liikevaihto

9,06 mrd.

EBIT %

26,35 %

P/E -luku

Osinkotuotto %

1,63 %

Tavoitehinta

Suositus

Päivitetty

NASDAQ Copenhagen

CHR

Päivän matalin / päivän korkein hinta

426,3 / 436,5 DKK

Markkina-arvo

57,01 mrd. DKK

Vaihto

52,55 milj. DKK

Vaihtomäärä, kappaletta

121 t.

Pörssikalenteri

Vuosikatsaus

12.10.2023

Yhtiökokous

22.11.2023

Suurimmat omistajat
Lähde: Millistream Market Data AB

Omistaja	Osuus	Ääniä
Novo Holdings	22,0 %	22,0 %
APG Asset Management	5,0 %	5,0 %

Inderes Premium

Premium ei aktivoitu

Tämä sisältö on vain Inderes Premium -käyttäjille.

Kirjaudu sisään Lue lisää

Näytä Kaikki sisältötyypit

Major shareholder announcements from Burlington Loan Management DAC and Davidson Kempner Capital Management LP

Pörssitiedote27.09.2023

Chr. Hansen Holding

Pörssikalenteri

Suurimmat omistajatLähde: Millistream Market Data AB

Inderes Premium

Major shareholder announcements from Burlington Loan Management DAC and Davidson Kempner Capital Management LP

Update on the combination of Novozymes and Chr. Hansen: Chinese merger approval granted, supporting the path to completion

Chr. Hansen Holding A/S Interim Report Q3 2022/23

Chr. Hansen Holding A/S Interim Report Q2 2022/23

Novozymes’ and Chr. Hansen’s shareholders approve combination to create a leading global biosolutions partner

Resolutions passed at the Extraordinary General Meeting of Chr. Hansen Holding A/S

Combination between Novozymes and Chr. Hansen approved by Novozymes’ shareholders

Update on the combination of Novozymes and Chr. Hansen: U.S. antitrust regulation waiting period has expired, supporting the path to completion

Notice to convene Extraordinary General Meeting

Publication of exemption document in relation to the proposed combination of Chr. Hansen and Novozymes, confirmation of outlook for 2022/23 and proposed candidates to the Board of Directors of the combined company

Novozymes and Chr. Hansen receive binding tax ruling that the proposed merger can be completed as a tax-exempt merger

Chr. Hansen Holding A/S Interim Report Q1 2022/23

Novozymes and Chr. Hansen to combine and create a leading global biosolutions partner

Manager’s transactions

Resolutions passed at the Annual General Meeting of Chr. Hansen Holding A/S

Vesting of restricted share units

Notice to convene the Annual General Metting 2022

Manager’s transactions

Chr. Hansen Annual Report 2021/22

Chr. Hansen Holding A/S - Major shareholder announcement from APG Asset Management N.V.

Suurimmat omistajat
Lähde: Millistream Market Data AB